{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:16:08Z","timestamp":1760098568573,"version":"3.40.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Clinical"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbacli.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T12:45:44Z","timestamp":1457700344000},"page":"124-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Expression levels of estrogen receptor \u03b1 mRNA in peripheral blood cells are an independent biomarker for postmenopausal osteoporosis"],"prefix":"10.1016","volume":"5","author":[{"given":"Chi-Wen","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsay-I","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Hung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-4423","authenticated-orcid":false,"given":"Ya-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbacli.2016.03.001_bb0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rcl.2010.02.010","article-title":"Osteoporosis: social and economic impact","volume":"48","author":"Compston","year":"2010","journal-title":"Radiol. Clin. N. Am."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0010","doi-asserted-by":"crossref","DOI":"10.1359\/jbmr.2001.16.12.2215","article-title":"Generation of bone-resorbing osteoclasts from B220+cells: its role in accelerated osteoclastogenesis due to estrogen deficiency","volume":"16","author":"Sato","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/dna.2006.25.475","article-title":"Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts","volume":"25","author":"Sorensen","year":"2006","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0020","first-page":"215","article-title":"Receptor activator of NF (kappa) B ligand\/osteoprotegerin (RANKL\/OPG) system and osteopontin (OPN) serum levels in a population of Apulian postmenopausal women","volume":"48","author":"D'Amore","year":"2006","journal-title":"Panminerva Med."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0025","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jor.20505","article-title":"Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model","volume":"26","author":"McCann","year":"2008","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S8756-3282(02)00953-5","article-title":"The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts","volume":"32","author":"Bord","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bbacli.2016.03.001_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2008.03.003","article-title":"Estrogen receptor subtype-specific effects on markers of bone homeostasis","volume":"291","author":"Hertrampf","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0040","doi-asserted-by":"crossref","first-page":"25501","DOI":"10.1074\/jbc.M702231200","article-title":"A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction","volume":"282","author":"Aguirre","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0045","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1359\/jbmr.1998.13.8.1275","article-title":"The estrogen receptor's involvement in osteoblasts' adaptive response to mechanical strain","volume":"13","author":"Damien","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/424389a","article-title":"Endocrinology: bone adaptation requires oestrogen receptor-alpha","volume":"424","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbacli.2016.03.001_bb0055","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1359\/jbmr.060504","article-title":"Osteocytes use estrogen receptor alpha to respond to strain but their ER alpha content is regulated by estrogen","volume":"21","author":"Zaman","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0060","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1210\/me.2014-1147","article-title":"Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics","volume":"28","author":"Liu","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00045391-200109000-00007","article-title":"Aromatase, aromatase inhibitors, and breast cancer","volume":"8","author":"Brueggemeier","year":"2001","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bone.2007.06.004","article-title":"Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates","volume":"41","author":"Confavreux","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bbacli.2016.03.001_bb0075","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1359\/jbmr.2001.16.11.1937","article-title":"Postmenopausal osteoporosis as a failure of bone's adaptation to functional loading: a hypothesis","volume":"16","author":"Lanyon","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1677\/joe.0.1820183","article-title":"Is estrogen receptor alpha key to controlling bones' resistance to fracture?","volume":"182","author":"Lanyon","year":"2004","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0085","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-009-1107-7","article-title":"Increased serum osteopontin is a risk factor for osteoporosis in menopausal women","volume":"21","author":"Chang","year":"2010","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0090","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ijc.21278","article-title":"Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer","volume":"117","author":"Lai","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbacli.2016.03.001_bb0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-011-0836-z","article-title":"Methylation of the promoter A of estrogen receptor alpha gene in hBMSC and osteoblasts and its correlation with homocysteine","volume":"355","author":"Lv","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0100","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1007\/s11033-012-1496-0","article-title":"Evaluation of ER\u03b1 and VDR gene polymorphisms in relation to bone mineral density in Turkish postmenopausal women","volume":"39","author":"Kurt","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbacli.2016.03.001_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/gme.0b013e318213545a","article-title":"Interactions of osteoporosis candidate genes for age at menarche, age at natural menopause, and maximal height in Han Chinese Women","volume":"18","author":"Zhao","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.bbacli.2016.03.001_bb0110","first-page":"137","article-title":"Therapeutic potential of oestrogen receptor ligands in development for osteoporosis","volume":"6","author":"Cho","year":"2001","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bbacli.2016.03.001_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CIA.S6083","article-title":"Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene","volume":"5","author":"Gennari","year":"2010","journal-title":"Clin. Interv. Aging"}],"container-title":["BBA Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T07:00:10Z","timestamp":1536908410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214647416300058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":23,"alternative-id":["S2214647416300058"],"URL":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.03.001","relation":{},"ISSN":["2214-6474"],"issn-type":[{"type":"print","value":"2214-6474"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression levels of estrogen receptor \u03b1 mRNA in peripheral blood cells are an independent biomarker for postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"BBA Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}